On November 19, 2024, the VASCO Knight @ VEITH 2024 conference was successfully held at the Hilton Hotel in Midtown, New York, USA. With the theme "Innovation and the Future," the event brought together global academic experts, industry leaders, and medical technology innovators to discuss the latest advancements in vascular surgery, intelligent healthcare, and future trends. This global platform provided valuable insights and directions for advancing medical technology and international collaboration.

Professor Shu Chang: Driving Integration of Academia and Industry to Establish New Patterns of International Medical Collaboration

As one of the conference chairs, Professor Shu Chang once again showcased his exceptional leadership in advancing the internationalization of vascular surgery through academic and industrial integration. By hosting various specialized forums and academic activities during the conference, Professor Shu engaged with experts worldwide to explore the future development of vascular intervention. Through the dual drivers of academia and industry, he further strengthened China's academic position in the international medical field and expanded the global presence of China's medical industry.

Collaborative Milestones: Signing of the CVC and SITE Agreement

During the conference, Professor Shu facilitated the signing of a collaboration agreement between the China Vascular Conference (CVC) and the Spanish Society of Angiology and Vascular Surgery (SITE). This memorandum of understanding marked a new chapter in international vascular surgery collaboration and provided strong momentum for medical technology exchange and international cooperation under the "Belt and Road" Initiative. By deepening cooperation with medical institutions in "Belt and Road" countries, China's vascular surgical innovations are being shared more widely with global patients suffering from vascular diseases.

Dual-Driven Strategy: Pioneering the Internationalization of Vascular Surgery

Professor Shu firmly believes that the deep integration of academia and industry is key to driving innovation and development in medical technology. At the 9th China Vascular Conference (CVC 2024), he joined leading vascular surgery experts from 32 countries and regions to share the latest clinical experiences and research outcomes. Through such platforms, Professor Shu not only showcased China's achievements in vascular surgery but also promoted the global application of Chinese innovations. The International Vascular Network Collaborative Group has not only elevated Chinese vascular surgery to a global stage but also set a valuable example for international medical academic collaboration.

Global Collaboration: The Role of Fangchenggang International Medical Open Trial Zone

The Fangchenggang International Medical Open Trial Zone, China's first open medical trial zone, played a pivotal role during the conference. Through policy support, resource integration, and international cooperation, this innovative practice has become a crucial platform for global medical device research and development, technology incubation, and commercialization. It has opened new avenues for the internationalization of China's medical technologies and provided practical support for medical collaborations under the "Belt and Road" Initiative.

Industry Innovation Forum: Bridging Technology Exchange and Cooperation

The Industry Innovation Forum was one of the highlights of the conference, showcasing multiple cutting-edge achievements in medical technology. The forum featured explorations ranging from intelligent medical devices to precision surgical solutions, including robotic-assisted technology, AI medical imaging, and biomechanical simulations for personalized treatment design. These innovations demonstrated the future directions of healthcare development. The forum underscored the capabilities of Chinese enterprises in medical innovation while providing more opportunities for cross-border technological cooperation and commercialization.

Looking Ahead: Creating New Horizons for International Medical Collaboration

By integrating academic and industrial resources, Professor Shu has built bridges for international exchange in medical technology, facilitating the global application of Chinese medical innovations. Moving forward, VASCO Knight (CVC) will continue to promote the globalization of vascular surgery techniques, setting an example for international medical collaboration.

Under the leadership of the dual drivers of academia and industry, Chinese vascular surgery will persist in technological innovation, contributing to the collaborative development of global health and offering more Chinese wisdom to benefit humanity.